Resources/Hyaluronic Acid in Cosmetics: Global Regulatory Status and Compliance
Hyaluronic Acid in Cosmetics: Global Regulatory Status and Compliance
Disclaimer: The information provided in this guide is for educational and regulatory context purposes only and does not constitute formal legal advice. Compliance requirements can vary based on formulation, regional authority updates, and specific product claims. Consult a certified regulatory affairs professional or specialized legal counsel for official filings.
Hyaluronic Acid (HA) and its derivatives are widely utilized in cosmetic formulations for their humectant and skin conditioning properties. Globally, HA is generally not subject to specific concentration limits or outright bans as a restricted substance in the same manner as certain preservatives or UV filters. Instead, its regulatory status is primarily governed by general cosmetic safety provisions, purity standards, and good manufacturing practices.
EU Cosmetics Regulation (EC) No 1223/2009
Under the EU Cosmetics Regulation, Hyaluronic Acid is not listed in Annex II (Prohibited Substances) or Annex III (Restricted Substances). Its use is permitted, provided the final cosmetic product is safe for human health when used under normal or reasonably foreseeable conditions. The safety assessment of the finished product, conducted by a qualified safety assessor, must consider the purity, molecular weight, and concentration of HA, especially concerning potential dermal penetration or irritation, though HA is generally well-tolerated.
- HA is not listed in EU Annex II or III.
- Safety is assessed under general product safety requirements (Article 3).
- Purity and molecular weight are key considerations for the Product Information File (PIF).
- No specific concentration limits are imposed on HA itself.
US FDA and MoCRA
In the United States, the Food and Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act, now significantly updated by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). HA is considered a cosmetic ingredient, and its use is not subject to pre-market approval. However, MoCRA places increased responsibility on the 'responsible person' (manufacturer, packer, or distributor) to ensure and substantiate the safety of cosmetic products and their ingredients. This includes maintaining records of adequate safety substantiation for HA.
- HA is treated as a cosmetic ingredient, not a drug.
- No specific restrictions or concentration limits are imposed by the FDA.
- The 'responsible person' must ensure and substantiate the safety of the ingredient and finished product under MoCRA.
- Good Manufacturing Practices (GMP) apply to the production of HA-containing cosmetics.
Asia-Pacific Markets (China NMPA, ASEAN)
In China, Hyaluronic Acid is listed in the Inventory of Existing Cosmetic Ingredients in China (IECIC), meaning it is permitted for use without new ingredient registration. However, specific purity standards and manufacturing processes are subject to NMPA oversight. Similarly, within the ASEAN Cosmetic Directive (ACD) framework, HA is generally permitted, aligning with the EU's approach of general safety assessment rather than specific ingredient restrictions. Manufacturers must ensure the ingredient's quality and safety for its intended use.
- China NMPA: HA is on the IECIC; no new ingredient registration typically required for standard forms.
- ASEAN Cosmetic Directive: Permitted under general safety principles.
- Purity and quality specifications are crucial in these markets.
- Novel forms or high concentrations might trigger additional scrutiny or notification requirements.
While Hyaluronic Acid is broadly permitted, ensuring compliance involves verifying the specific purity grade, molecular weight, and any associated supplier documentation against the latest regulatory interpretations for your target market. To confirm the current regulatory status, including any specific local nuances or emerging considerations for your exact HA derivative and intended product type, consult TML's compliance engine or perform a quick public search for the most up-to-date information.
This content was generated by AI. Always verify the information before use.